Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/9536
Title: Blinded, Double‐Dummy, Parallel‐Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5‐Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance
Authors: Marianne J. Chapman
Karen L. Jones
Cristina Almansa
Chris N. Barnes
Deanna Nguyen
Adam M. Deane
Issue Date: Jan-2021
Journal: Journal of Parenteral and Enteral Nutrition
Appears in Sites:Publication workflow
Queensland Health Publications

Show full item record

Page view(s)

12
checked on Jul 17, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.